JPIAMR – JPIAMR

Thank you JPIAMR, welcome EUP OHAMR!

Jun 16, 2025Jun 16, 2025 Anna SundinNews and press

After 14 years of joint international collaboration, the JPIAMR officially ended on 31 May 2025. The programme is succeeded by the new European Partnership on One Health Antimicrobial Resistance (EUP OHAMR), which starts in June 2025.

During the years, JPIAMR has successfully coordinated national research funding and supported collaborative actions for filling knowledge gaps on AMR with a One Health perspective. Together with 29 member countries and the European Commission, JPIAMR supported close to 1900 researchers to collaborate across national and scientific borders to find new treatments, solutions and methods to tackle AMR.

The JPIAMR secretariat would like to thank the JPIAMR member countries, boards and committees, as well as stakeholders, experts and researchers for their support and engagement over the years. Together, we have generated knowledge and capacity building in all the divers priority areas of the JPIAMR Strategic Research and Innovation Agenda, giving the global community resources and tools to understand and reduce the societal burden of AMR.

We look forward to continuing the work initiated by JPIAMR in the new EUP OHAMR and evolving and progressing together.

/The JPIAMR secretariat

Video switcher table at the JPIAMR final conference.

Voices on the impact of JPIAMR and expectations for the EUP OHAMR

Jun 16, 2025Jun 16, 2025 Anna SundinNews and press

At the JPIAMR Final Conference in May, we asked Jan-Ingvar Jönsson, Chair of JPIAMR, and Till Bachmann and Sabiha Essack from the JPIAMR Scientific Advisory Board to share some key achievements of JPIAMR and their wishes and expectations for the new European Partnership on One Health Antimicrobial Resistance (EUP OHAMR).

We also met with Prof. Dame Sally Davies, Special Envoy on AMR for the UK, and Irene Norstedt, Director, DG Research and Innovation, European Commission, to hear their thoughts on AMR research prioritisation, existing knowledge gaps in the AMR field and the importance of One Health and international collaboration in the EUP OHAMR.

Watch the interviews here:

Interviews from the JPIAMR Final Conference (YouTube playlist)

Final conference highlighted the success of JPIAMR

Jun 16, 2025Jun 16, 2025 Anna SundinNews and press

World-leading researchers, experts, stakeholders and funders gathered in Stockholm, Sweden, on 7-8 May for a conference to highlight the impact of 10 years of transnational AMR research supported by JPIAMR. During the conference, 135 participants from 30 countries came together for presentations on research outputs and outcomes and further discussions, creating a unique opportunity for knowledge-sharing across disciplines and sectors. The conference also marked the milestone of the JPIAMR transitioning to the European Partnership on One Health Antimicrobial Resistance (EUP OHAMR).

The programme included scientific sessions, keynote talks and poster pitch presentations from JPIAMR supported projects and networks, as well as thematic group discussions in a world café format (picture below).

One of the many highlights from the conference was the performance from LIFELINE the Musical, followed by a discussion with Prof. Dame Sally Davies, Special Envoy on AMR for the UK, and Irene Norstedt, Director, DG Research and Innovation, European Commission, on novel science communication and One Health.

Learn more

Participants at the JPIAMR Final conference.

JPIAMR at the AMR Multi-Stakeholder Partnership Platform Plenary Assembly

Nov 25, 2024Dec 20, 2024 Anna SundinNews and pressLeave a Comment

JPIAMR took part in the 2nd Annual Plenary Assembly of the AMR Multi-Stakeholder Partnership Platform (MSPP) that was held on 16 November in Jeddah, Saudi Arabia. The MSPP was established and facilitated by the Quadripartite organizations (FAO, UNEP, WHO and WOAH) in 2023 with the aim to catalyse a global movement for action against antimicrobial resistance (AMR) by fostering cooperation between a diverse range of stakeholders at all levels across the One Health spectrum.

The platform’s members shared progress and experiences since its inception and worked together on formulating concrete steps for implementation of the UNGA political declaration on AMR from September this year.

The annual assembly was held in conjunction with the Fourth High-level Ministerial Conference on AMR, which highlighted efforts and ambitions in infection prevention, diagnostics, and research and innovation. The importance of inclusivity of voices and perspectives and of securing sustainable financial resources to support all aspects of AMR mitigation was highlighted by panelists and speakers.

A few key points from JPIAMR’s perspective:

Basic research and innovation, and good scientists, are needed for sustainable access to antibiotics.
Repeated calls for comprehensive funding for research and innovation with a One Health perspective, from public and private sector representatives.
Research and knowledge valorisation in infection prevention, diagnostics, and optimal use of existing antibiotics are accessible solutions for immediate action.
To tackle AMR, we need to also recognize how it is situated in a system of poor basic health care, lack of clean water and sanitation, impact from conflicts and climate change, and the vulnerable balance between access to/excess of medications.

Call picture AMR Interventions call 2024.

New projects in the area of AMR interventions

Nov 18, 2024Nov 18, 2024 Anna SundinNews and press

Thirteen projects involving 64 partners from 15 different countries have been recommended for funding within the JPIAMR 17th transnational call: Interventions moving forward to promote action to counteract the emergence and spread of bacterial and fungal resistance and to improve treatments. The call was within the framework of the ERA‐NET JPIAMR-ACTION and the total funding amount is 17,2 M€.

The projects aim to improve, compare and evaluate the effectiveness, cost effectiveness, and uptake of existing interventions against bacterial or fungal infections and/or to design new interventions against fungal infections, by focusing on the two topics of the call:

To design novel or improved interventions to prevent, mitigate and /or treat fungal infections, which are resistant to treatments and/or are at risk of developing resistance.
To improve and/or, compare and/or evaluate strategies, technologies, treatments, methods, protocols or data collection based on existing interventions, aiming to prevent or reduce the emergence or spread of antibacterial or antifungal resistance or to treat/cure infections caused by resistant bacteria/fungi and recommend new policies.

JPIAMR at ECCMID 2023

Mar 9, 2023Mar 9, 2023 Anna SundinNews and press

The 33rd European Congress of Clinical Microbiology & Infectious Diseases, ECCMID, will take place in Copenhagen, Denmark, on 15-18 April 2023.

JPIAMR is co-organising the session Developing your funding application: from drug discovery to drug development on 16 April at 12:15-13:15 CEST.

Programme:

12:15 – Marc Lemonnier (Labege, France)

12:20 – JPIAMR funding calls and funding for academic research, Laura Marin (JPIAMR)

12:30 – Translating your research, Philip Packer (Innovate UK)

12:40 – Funding your innovation, Ursula Theuretzbacher (Center for Anti-Infective Agents, Austria)

12:50 – Q&A

13:15 – Wrap-up & End of session

Call picture for JPIAMR Diagnostics and Surveillance call 2023

Research call on AMR Diagnostics and surveillance now open

Jan 16, 2023Jan 16, 2023 Anna SundinNews and press

The call Development of innovative strategies, tools, technologies, and methods for diagnostics and surveillance of antimicrobial resistance is now open.

This call aims to fund research projects developing novel or improving existing strategies, tools, technologies and methods for diagnosis and/or One Health AMR surveillance. It involves 22 funding organisations from 18 countries and has a total estimated call budget of 18,8 M€.

Partners working in eligible Least Developed Countries (LDCs) in in sub-Saharan Africa can be funded by the Swedish International Development Cooperation Agency (Sida).

The call will follow a two-step evaluation procedure and the deadline for pre-proposals is 7 March 2022. The full call text and the link to the online submission platform can be found on the call page:

Call page “AMR diagnostics and surveillance 2023”

Webinar for applicants

A live webinar for applicants will be organised on the 24th of January 2023. This webinar will present the call and the partner search tool. Representatives from funders participating in the call will answer questions live.

Registration page Webinar for applicants

Shadows of people on a colourful background.

Six new networks in the area of diagnostics and surveillance

Nov 18, 2022Nov 17, 2023 Anna SundinNews and pressLeave a Comment

Six networks have been recommended for funding within the JPIAMR 15th transnational call: Diagnostics and Surveillance Networks. The networks include 228 partners from 40 countries and the total funding amount is 300 000 € plus up to 100 000 € fort start-up and final joint workshops.

The networks assemble leading experts and stakeholders with an intent to facilitate the development, optimisation and use of diagnostic and surveillance tools, technologies and systems.

For the first time, a network focussed on antifungal resistance has been included.

Learn more about the networks

New projects in the area of therapeutics

Nov 18, 2022Nov 18, 2022 Anna SundinNews and pressLeave a Comment

Thirteen projects involving 72 partners from 15 different countries have been recommended for funding within the JPIAMR 14th transnational call: Disrupting drug Resistance Using Innovative Design. The call was within the framework of the ERA‐NET JPIAMRACTION and the total funding amount is 15,4 M€.

The projects aim to improve the treatment of bacterial and fungal infections (including co-infection) and/or the prevention of the emergence/spread of resistance in humans, animals or plants through the improvement of the efficacy, specificity, delivery, combinations and/or repurposing of drugs and plant protection agents.

Learn more about the projects

Pre-announcement: Research call on AMR diagnostics and surveillance

Nov 18, 2022Jan 16, 2023 Anna SundinNews and pressLeave a Comment

We are pleased to pre‐announce the transnational call Development of innovative strategies, tools, technologies, and methods for diagnostics and surveillance of antimicrobial resistance.

This call aims to fund research projects developing novel or improving existing strategies, tools, technologies and methods for diagnosis and/or One Health AMR surveillance. It involves 21 funding organisations from 18 countries and has a total estimated call budget of 18,8 M€.

N.B New opening date! The call opens on 16 January 2023.